EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Adrien M Vaquié, Davod R Shah, Eliane E S Brechbühl, Michael McNicholas, Zhaoyang Xu, John H Stockley, Laura Morcom, Diana Gold Diaz, Gemma C Girdler, Rachel V Seear, Gabriel Balmus, Rajiv R Ratan und 5 weitere

Molecular Oncology · 2025

DOI: 10.1002/1878-0261.70128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Oncology, 2025. Verfasst von Adrien M Vaquié und 16 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, UK. Hauptthemen laut MEDLINE: Cholesterol, Neoplastic Stem Cells, Glioma, Iron. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council Advanced Grant, Wellcome Trust, Swiss National Science foundation (SNSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioma stem cells (GSCs) from this aggressive brain cancer have been subject to nononcogene addiction therapeutic strategies, in particular targeting iron and cholesterol metabolic pathways. In this study, we show the small molecule Adaptaquin (AQ) has anti‐GSC effects while sparing neurons, mature oligodendrocytes and astrocytes. Transcriptomic analysis of AQ‐treated GSCs showed dramatic upregulation of iron transport genes and downregulation of genes involved in cholesterol biosynthesis. Indeed, we found cytotoxic effects of AQ on GSCs were potentiated when combined with the iron chelator deferoxamine (DFO). Notably, these effects were independent of PHD2 and HIF1α regulation, indicating a distinct pathway of action. Furthermore, we observed that the heme analogue, hemin, protects GSCs from AQ‐mediated cell death, suggesting the presence of a functional heme transporter in GSCs, an observation confirmed by uptake of heme analogues. Importantly, we found that AQ treatment alone or in combination with iron chelators impaired cholesterol homeostasis in GSCs, leading to mitochondrial fragmentation and cell death. These findings suggest AQ in combination with iron chelators results in lethal disruption of cholesterol metabolism in glioma stem cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholesterolNeoplastic Stem CellsGliomaIronBrain NeoplasmsHumansCell Line, TumorIron Chelating AgentsAnimalsDeferoxamine

Stichwörter der Autor:innen

Adaptaquincholesteroldeferoxamineglioma stem cellsironnononcogene addiction

Substanzen

CholesterolIronIron Chelating AgentsDeferoxamine

Autor:innen und Institutionen

  • Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, UK.
  • Department of Paediatrics, Biomedical Campus, University of Cambridge, UK.
  • Cancer Research-UK, Cambridge Research Institute, University of Cambridge, UK.
  • Department of Oncology, Early Cancer Institute, University of Cambridge, UK.
  • Cancer Research-UK, Children's Brain Tumour Centre of Excellence, University of Cambridge, UK.
  • Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), University of Cambridge, UK.

ORCID-Profile: Harry Bulstrode, James A Nathan, David H Rowitch

Förderung

  • European Research Council Advanced Grant
  • Wellcome Trust
  • Swiss National Science foundation (SNSF)
  • Dr Miriam and Sheldon G. Adelson Medical Research Foundation
  • NIHR Cambridge Biomedical Research Centre
  • Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Zitieren

APA

Vaquié, A. M., Shah, D. R., Brechbühl, E. E. S., McNicholas, M., Xu, Z., Stockley, J. H., Morcom, L., Gold Diaz, D., Girdler, G. C., Seear, R. V., Balmus, G., Ratan, R. R., Bulstrode, H., Nathan, J. A., Pathania, M., Brindle, K. M., & Rowitch, D. H. (2025). Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism. Molecular Oncology. https://doi.org/10.1002/1878-0261.70128

Vancouver

Vaquié AM, Shah DR, Brechbühl EES, McNicholas M, Xu Z, Stockley JH, et al. Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism. Molecular Oncology. 2025. doi:10.1002/1878-0261.70128

BibTeX
@article{Vaqui2025,
  author = {Vaquié, Adrien M and Shah, Davod R and Brechbühl, Eliane E S and McNicholas, Michael and Xu, Zhaoyang and Stockley, John H and Morcom, Laura and Gold Diaz, Diana and Girdler, Gemma C and Seear, Rachel V and Balmus, Gabriel and Ratan, Rajiv R and Bulstrode, Harry and Nathan, James A and Pathania, Manav and Brindle, Kevin M and Rowitch, David H},
  title = {Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism},
  journal = {Molecular Oncology},
  year = {2025},
  doi = {10.1002/1878-0261.70128}
}
Kostenlos starten →